Search

Toya D Kimble

from Memphis, TN
Age ~55
Get Report
Also known as:
Toya Denise Kimble, Toya H Kimble, Toya D Hurt, Yoya D Kimble, Justin Roland
Phone and address:
5873 Hickory Cmns, Memphis, TN 38141
Related to:
Michael C Harris, 78Jimmy L Kimble, 77Yvette D Cooper, 56Eltrae Hurt, 53Mark A Kimble, 54Kathleen L Hurt, 74Jimmy Kimble, 64Kathleen L Hurt, 83Ester Lee Hurt, 53
Connected to:
Allyson M Kimble, 38Amanda Kimble, 47Anoka E Kimble, 75Aramis Kimble, 39Ashlee R Kimble, 39Autumn D Kimble, 48Barry Kimble, 67Beth M Kimble, 58Betsy C Kimble, 92Beverly A Kimble, 61

Toya Kimble Phones & Addresses

  • 5873 Hickory Cmns, Memphis, TN 38141
  • Holt, MI
  • 5873 Hickory Commons, Memphis, TN 38141

Work

Position: Clerical/White Collar

Education

Degree: Graduate or professional degree

Resumes

Resumes

Toya Kimble Photo 1

Assistant Director - Baptist Clinical Research Institute

View page
Location:
Memphis, TN
Industry:
Hospital & Health Care
Work:
Baptist Memorial Health Care
Assistant Director - Baptist Clinical Research Institute
Ut Medical Group May 2015 - Apr 2016
Administrative Graduate Assistant - Clinical Operations
Currently Seeking New Position As Project Leader Jun 2012 - May 2015
Biopharma Product Development Scientist | Project Manager
Medtronic Nov 2005 - Jun 2012
Senior Scientist
University of Tennessee Health Science Center Jan 2003 - Nov 2005
Postdoctoral Student
Education:
The University of Memphis 2014 - 2016
Masters, Management, Health Administration, Health Care Administration The University of Tennessee Health Science Center 1995 - 2003
Doctorates, Doctor of Philosophy, Neuroscience Christian Brothers University 1989 - 1993
Bachelors, Bachelor of Science, Biology
Skills:
Biopharmaceuticals
Glp
Cross Functional Team Leadership
Project Management
Biotechnology
Cro
Regulatory Submissions
Leadership
Drug Development
Commercialization
Gmp
Healthcare Management
Public Speaking
Pharmaceutical Industry
R&D
Lifesciences
Animal Models
Toxicology
Ind
Design Control
Healthcare
Medical Devices
Management
U.s. Food and Drug Administration
Issue Resolution
Meaningful Use
Ehr
Physician Quality Reporting System
Product Development
Non Clinical Toxicology
Non Clinical Safety
Pre Ind Submissions
Ich Guidelines
Fda Glp
Sop Development
Technical Writing
Fda
Orthopedic
Investigational New Drug Submissions
Fda Gmp
Interests:
Education
Toya Kimble Photo 2

Assistant Director

View page
Location:
Memphis, TN
Industry:
Hospital & Health Care
Work:
Baptist Memorial Health Care
Assistant Director
Toya Kimble Photo 3

Toya Kimble

View page

Publications

Us Patents

Biological Markers And Response To Treatment For Pain, Inflammation, Neuronal Or Vascular Injury And Methods Of Use

View page
US Patent:
20090263507, Oct 22, 2009
Filed:
Apr 18, 2008
Appl. No.:
12/105666
Inventors:
Josee ROY - Memphis TN, US
Toya D. Kimble - Memphis TN, US
Assignee:
Warsaw Orthopedic, Inc. - Warsaw IN
International Classification:
A61K 33/06
A61P 43/00
US Classification:
424682
Abstract:
The invention provides methods and kits for treatment of pain, inflammation, neuronal or vascular injury and the use of biomarkers for the assessment of the biological activity or disease state. In one embodiment, the kit comprises a biomembrane sealing agent, such as PEG, a bioactive agent, such as a magnesium compound, and an assay for measuring a biomarker. The biomarker is measured pre-, mid- and post-treatment, and results of the measurements are compared to evaluate the treatment, treatment regimen and outcomes.

Drug Depot Implantable Within A Joint

View page
US Patent:
20100015196, Jan 21, 2010
Filed:
Jul 16, 2008
Appl. No.:
12/174007
Inventors:
Toya D. Kimble - Memphis TN, US
Susan J. Drapeau - Memphis TN, US
William F. McKay - Memphis TN, US
John Myers Zanella - Memphis TN, US
Erica Tenbroek - Minneapolis MN, US
Assignee:
WARSAW ORTHOPEDIC, INC. - Warsaw IN
International Classification:
A61K 9/00
A61P 29/00
A61P 25/00
US Classification:
424423
Abstract:
Methods and compositions for treating a tissue within a synovial joint in a patient in need of such treatment are provided. The methods and compositions involve inserting a drug depot through the synovial joint and attaching the drug depot to the inside of the synovial joint capsule so that the drug depot does not substantially interfere with movement of the joint, wherein said depot comprises a polymer and at least one pharmaceutical agent.

Compositions And Methods For Preferential Distribution Of Active Agents To Injury Sites

View page
US Patent:
20100247677, Sep 30, 2010
Filed:
Mar 26, 2009
Appl. No.:
12/411572
Inventors:
Josee Roy - Memphis TN, US
Toya Kimble - Memphis TN, US
Assignee:
WARSAW ORTHOPEDIC, INC. - Warsaw IN
International Classification:
A61K 33/06
A61P 25/00
US Classification:
424682
Abstract:
Compositions are provided for preferential distribution of active agents to injury sites. Such compositions may comprise a ligand with hydrophilic properties and one or more active agents, such as compounds comprising hydrophilic metal ions. Because the delivery ligand and the active agent are specifically selected so the interactions between them are mainly of an ionic nature so that binding of the active agent to the delivery ligand and release of the active agent into the target site are not dependent on enzymatic activity. Methods of using such compositions are also disclosed.

Device To Deliver Magnesium In Peg Formulation

View page
US Patent:
20100249699, Sep 30, 2010
Filed:
Mar 26, 2009
Appl. No.:
12/411537
Inventors:
Josee ROY - Memphis TN, US
Toya D. Kimble - Memphis TN, US
Jeffery C. Marx - Germantown TN, US
Assignee:
Warsaw Orthopedic, Inc. - Warsaw IN
International Classification:
A61M 37/00
B65D 25/08
US Classification:
604 84, 604 87, 604416, 206222
Abstract:
A container supplies a medicinal formulation that includes a hydrophilic polymer and an active agent capable of bonding to the polymer. The container includes a first compartment for storing the polymer and a second compartment fluidly isolated from the first compartment for storing the active agent. A frangible barrier is shared between the compartments. A fluidic outlet is disposed on the container to dispense the medicinal formulation. Dispensing of the medicinal formulation includes rupturing the frangible barrier, mixing the polymer and active agent together to form the medicinal formulation, and administering the medicinal formulation provided from the fluidic outlet to a patient. The polymer can be PEG, while the active agent can be magnesium.

Compositions And Methods For Preferential Distribution Of Active Agents To Injury Sites

View page
US Patent:
20150030703, Jan 29, 2015
Filed:
Oct 3, 2014
Appl. No.:
14/506140
Inventors:
- Warsaw IN, US
Toya Kimble - Memphis TN, US
International Classification:
A61K 33/06
A61K 47/10
US Classification:
424682
Abstract:
Compositions are provided for preferential distribution of active agents to injury sites. Such compositions may comprise a ligand with hydrophilic properties and one or more active agents, such as compounds comprising hydrophilic metal ions. Because the delivery ligand and the active agent are specifically selected so the interactions between them are mainly of an ionic nature so that binding of the active agent to the delivery ligand and release of the active agent into the target site are not dependent on enzymatic activity. Methods of using such compositions are also disclosed.
Control profile
Toya D Kimble from Memphis, TN, age ~55 Get Report